Stimulators of soluble guanylyl cyclase: future clinical indications.
Department of Anesthesiology, Section of Critical Care Medicine, Ochsner Clinic Foundation, and ; The University of Queensland School of Medicine, Ochsner Clinical School, New Orleans, LA ; Department of Pharmacology, Tulane University School of Medicine, New Orleans, LA.
- Published Article
The Ochsner journal
- Publication Date
Jan 01, 2013
Animal and early clinical studies have shown that sGC stimulator agents have great promise for treating cardiopulmonary disorders and may also have a role in modulating the inflammatory response observed in perioperative care.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 06/09/2018 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/23532174